Myriad Genetics Inc (MYGN)
31.15
-0.10 -0.32%
NASDAQ
Dec 14, 20:00
Delayed 2m
USD
View All Key Stats
MYGN Key Stats
| Income Statement | |
| Revenue (TTM) | 784.70M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.68 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 49.30M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 75.43% |
| Profit Margin (Quarterly) | -0.35% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 2.329B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.88 |
| PE Ratio (TTM) | 45.81 |
| Price to Book Value | 2.113 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 6.50M |
| Return on Equity (TTM) | Upgrade |
View All MYGN News
MYGN News
-
WireHeadlineTime (ET)
-
Yahoo12/14 22:12
-
Yahoo12/11 08:42
-
Yahoo12/10 09:49
-
Yahoo12/10 08:45
-
MT Newswires12/07 09:36
-
Yahoo12/07 08:32
-
Globe Newswire12/07 08:32
-
Globe Newswire12/07 08:30
-
Globe Newswire12/06 08:30
-
Yahoo12/05 08:06
View All Events
MYGN Events
| Date | Type | Description |
|---|---|---|
| 02/06/2019 16:30 EST | Misc | Myriad Genetics Inc Second Quarter Earnings Conference Call in 2019 |
| 02/06/2019 | Earnings | Myriad Genetics Inc Second Quarter Earnings in 2019 Release |
| 11/06/2018 16:30 EST | Misc | Myriad Genetics Inc First Quarter Earnings Conference Call in 2019 |
| 11/06/2018 | Earnings | Myriad Genetics Inc First Quarter Earnings in 2019 Release |
| 08/24/2018 | Misc | Myriad Genetics Inc Annual Report in 2018 |
| 08/14/2018 16:30 EDT | Misc | Myriad Genetics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 08/14/2018 | Earnings | Myriad Genetics Inc Fourth Quarter Earnings Results in 2018 |
| 05/28/2018 | Misc | Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc |
| 05/08/2018 07:30 EDT | Misc | Myriad Genetics Inc Third Quarter Earnings Conference Call in 2018 |
| 05/08/2018 | Earnings | Myriad Genetics Inc Third Quarter Earnings Results in 2018 |
MYGN Fundamentals
Income Statement View Statement
MYGN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MYGN One Page Reports
- One Page Report Download
MYGN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 31.15 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.myriad.com
- Investor Relations URL: https://myriad.com/news-center/investor-information/
- HQ State/Province: Utah
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Growth
- Next Earnings Release: Feb. 06, 2019
- Last Earnings Release: Nov. 06, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
MYGN Excel Add-In Codes
- Name: =YCI("MYGN","name")
- Description: =YCI("MYGN","description")
- Sector: =YCI("MYGN","sector")
- Industry: =YCI("MYGN","industry")
- Est. Current Fiscal Year End: =YCI("MYGN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MYGN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MYGN Tweets Stocktwits
Advertisement
